# Ocumetics Technology Corp fundraising

> Live situation record from CLSTR: https://clstr.news/situations/ocumetics-technology-corp-fundraising
> Updated: 2026-08-07T13:02:04.000Z. Sources: 2. Developments: 2.

Ocumetics Technology Corp. completed the second tranche of a private placement, issuing 6,250,000 units at $0.40 each. This brought the total proceeds from the offering to $2,948,130, with a potential maximum of $3.2 million. The funds are intended to support the company's first-in-human clinical trials for its dynamic intraocular lens, ongoing research and development, and general working capital.

## Timeline

### 2026-08-07: Ocugen and Oculis report quarterly financial results

Biotech firms Ocugen and Oculis released quarterly results; Ocugen plans Phase 3 trials for OCU410, while Oculis surpassed earnings per share estimates.

2 sources. https://clstr.news/cluster/ocugen-and-oculis-report-quarterly-financial-results

### 2026-07-31: Ocumetics Technology Corp raises $2.5 million in private placement

Ocumetics Technology Corp completed a $2.5 million second tranche of its private placement, bringing total proceeds to about $2.95 million to fund first‑in‑human trials of its dynamic intraocular lens.

2 sources. https://clstr.news/cluster/ocumetics-technology-corp-raises-25-million-in-private-placement

---
Cite as: Ocumetics Technology Corp fundraising. CLSTR, https://clstr.news/situations/ocumetics-technology-corp-fundraising